相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections
Mario Mardirossian et al.
AMINO ACIDS (2016)
Efficacy of the Novel Antibiotic POL7001 in Preclinical Models of Pseudomonas aeruginosa Pneumonia
Cristina Cigana et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Esculentin-1a-Derived Peptides Promote Clearance of Pseudomonas aeruginosa Internalized in Bronchial Cells of Cystic Fibrosis Patients and Lung Cell Migration: Biochemical Properties and a Plausible Mode of Action
Floriana Cappiello et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Antimicrobial peptides (AMPs) as drug candidates: a patent review (2003-2015)
Paulina Kosikowska et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2016)
Emergence of colistin-resistant bacteria in humans without colistin usage: a new worry and cause for vigilance
Abiola Olumuyiwa Olaitan et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Carbapenem resistance mediated by blaOXA-181 in Pseudomonas aeruginosa
Daniele Meunier et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
INNATE IMMUNE SIGNALING ACTIVATED BY MDR BACTERIA IN THE AIRWAY
Dane Parker et al.
PHYSIOLOGICAL REVIEWS (2016)
Cationic host defense peptides; novel antimicrobial therapeutics against Category A pathogens and emerging infections
Fern Findlay et al.
PATHOGENS AND GLOBAL HEALTH (2016)
In vitro and in vivo efficacy, toxicity, bio-distribution and resistance selection of a novel antibacterial drug candidate
Jlenia Brunetti et al.
SCIENTIFIC REPORTS (2016)
Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients
Oana Ciofu et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
D-Amino acids incorporation in the frog skin-derived peptide esculentin-1a(1-21)NH2 is beneficial for its multiple functions
Antonio Di Grazia et al.
AMINO ACIDS (2015)
Peptide therapeutics: current status and future directions
Keld Fosgerau et al.
DRUG DISCOVERY TODAY (2015)
New pharmacokinetic/pharmacodynamic studies of systemically administered colistin against Pseudomonas aeruginosa and Acinetobacter baumannii in mouse thigh and lung infection models: smaller response in lung infection
Soon-Ee Cheah et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Emerging bacterial pathogens and changing concepts of bacterial pathogenesis in cystic fibrosis
Michael D. Parkins et al.
JOURNAL OF CYSTIC FIBROSIS (2015)
Fighting microbial infections: A lesson from amphibian skin-derived esculentin-1 peptides
Maria Luisa Mangoni et al.
PEPTIDES (2015)
The Frog Skin-Derived Antimicrobial Peptide Esculentin-1a(1-21)NH2 Promotes the Migration of Human HaCaT Keratinocytes in an EGF Receptor-Dependent Manner: A Novel Promoter of Human Skin Wound Healing?
Antonio Di Grazia et al.
PLOS ONE (2015)
Conditions Associated with the Cystic Fibrosis Defect Promote Chronic Pseudomonas aeruginosa Infection
Benjamin J. Staudinger et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
NDM carbapenemases in the United Kingdom: an analysis of the first 250 cases
Anu Jain et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Cathelicidin Host Defence Peptide Augments Clearance of Pulmonary Pseudomonas aeruginosa Infection by Its Influence on Neutrophil Function In Vivo
Paula E. Beaumont et al.
PLOS ONE (2014)
SPLUNC1/BPIFA1 Contributes to Pulmonary Host Defense against Klebsiella pneumoniae Respiratory Infection
Yang Liu et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Dual Acute Proinflammatory and Antifibrotic Pulmonary Effects of Short Palate, Lung, and Nasal Epithelium Clone-1 after Exposure to Carbon Nanotubes
Y. Peter Di et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2013)
Esculentin(1-21), an amphibian skin membrane-active peptide with potent activity on both planktonic and biofilm cells of the bacterial pathogen Pseudomonas aeruginosa
Vincenzo Luca et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
Future directions for peptide therapeutics development
Allan A. Kaspar et al.
DRUG DISCOVERY TODAY (2013)
Peptides as the next generation of anti-infectives
Derry K. Mercer et al.
FUTURE MEDICINAL CHEMISTRY (2013)
Increased Susceptibility to Pulmonary Pseudomonas Infection in Splunc1 Knockout Mice
Yanyan Liu et al.
JOURNAL OF IMMUNOLOGY (2013)
Barrier function of airway tract epithelium
Shyamala Ganesan et al.
TISSUE BARRIERS (2013)
PhoQ Mutations Promote Lipid A Modification and Polymyxin Resistance of Pseudomonas aeruginosa Found in Colistin-Treated Cystic Fibrosis Patients
Amanda K. Miller et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Host-defense peptides: from biology to therapeutic strategies
Maria Luisa Mangoni
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Antimicrobial Activity of PLUNC Protects against Pseudomonas aeruginosa Infection
Lina Lukinskiene et al.
JOURNAL OF IMMUNOLOGY (2011)
Management of refractory Pseudomonas aeruginosa infection in cystic fibrosis
Roger Sorde et al.
Infection and Drug Resistance (2011)
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Helen W. Boucher et al.
CLINICAL INFECTIOUS DISEASES (2009)
Esculentin 1-21: a linear antimicrobial peptide from frog skin with inhibitory effect on bovine mastitis-causing bacteria
Alfonso Enrique Islas-Rodriguez et al.
JOURNAL OF PEPTIDE SCIENCE (2009)
Pseudomonas aeruginosa Biofilms in the Respiratory Tract of Cystic Fibrosis Patients
Thomas Bjarnsholt et al.
PEDIATRIC PULMONOLOGY (2009)
Incidence and risk factors for multiple antibiotic-resistant Pseudomonas aeruginosa in cystic fibrosis
Christian A. Merlo et al.
CHEST (2007)
Cationic host defence peptides: Innate immune regulatory peptides as a novel approach for treating infections
N. Mookherjee et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Peptide antimicrobial agents
Havard Jenssen et al.
CLINICAL MICROBIOLOGY REVIEWS (2006)
The future should not look like the past
[Anonymous]
LANCET INFECTIOUS DISEASES (2006)
Cationic host defense (antimicrobial) peptides
KL Brown et al.
CURRENT OPINION IN IMMUNOLOGY (2006)
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Jian Li et al.
LANCET INFECTIOUS DISEASES (2006)
Antimicrobial peptide therapeutics for cystic fibrosis
LJ Zhang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Innate immunity in the lung: how epithelial cells fight against respiratory pathogens
R Bals et al.
EUROPEAN RESPIRATORY JOURNAL (2004)
Functional characterisation of the 1-18 fragment of esculentin-1b, an antimicrobial peptide from Rana esculenta
ML Mangoni et al.
PEPTIDES (2003)
Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation
E Drenkard et al.
NATURE (2002)
分享论文
